234 related articles for article (PubMed ID: 26894297)
21. Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Pal S; Bansil P; Bancone G; Hrutkay S; Kahn M; Gornsawun G; Penpitchaporn P; Chu CS; Nosten F; Domingo GJ
Am J Trop Med Hyg; 2019 Jan; 100(1):213-221. PubMed ID: 30350771
[TBL] [Abstract][Full Text] [Related]
22. Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.
Sadhewa A; Panggalo LV; Nanine I; Price RN; Thriemer K; Satyagraha AW; Ley B
PLoS One; 2024; 19(4):e0301506. PubMed ID: 38687748
[TBL] [Abstract][Full Text] [Related]
23. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
24. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
25. Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
Djigo OKM; Ould Khalef Y; Ould Ahmedou Salem MS; Gomez N; Basco L; Briolant S; Ould Mohamed Salem Boukhary A
Infect Dis Poverty; 2021 Aug; 10(1):105. PubMed ID: 34353361
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Tabatabaei SM; Salimi Khorashad A; Sakeni M; Raeisi A; Metanat Z
J Infect Dev Ctries; 2015 Mar; 9(3):289-97. PubMed ID: 25771467
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.
Aung TH; Suansomjit C; Tun ZM; Hlaing TM; Kaewkungwal J; Cui L; Sattabongkot J; Roobsoong W
Malar J; 2023 May; 22(1):143. PubMed ID: 37127600
[TBL] [Abstract][Full Text] [Related]
28. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti.
von Fricken ME; Weppelmann TA; Eaton WT; Masse R; Beau de Rochars MV; Okech BA
Am J Trop Med Hyg; 2014 Jul; 91(1):77-80. PubMed ID: 24778197
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
[TBL] [Abstract][Full Text] [Related]
31. Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
Jalloh A; Tantular IS; Pusarawati S; Kawilarang AP; Kerong H; Lin K; Ferreira MU; Matsuoka H; Arai M; Kita K; Kawamoto F
Trop Med Int Health; 2004 May; 9(5):615-23. PubMed ID: 15117307
[TBL] [Abstract][Full Text] [Related]
32. Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
Djigo OKM; Bollahi MA; Hasni Ebou M; Ould Ahmedou Salem MS; Tahar R; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A
PLoS One; 2019; 14(9):e0220977. PubMed ID: 31525211
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
Malar J; 2016 Feb; 15():82. PubMed ID: 26864333
[TBL] [Abstract][Full Text] [Related]
34. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
Lee W; Lee SE; Lee MJ; Noh KT
Malar J; 2020 Sep; 19(1):317. PubMed ID: 32873296
[TBL] [Abstract][Full Text] [Related]
35. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
[TBL] [Abstract][Full Text] [Related]
36. Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Deng Z; Yang F; Bai Y; He L; Li Q; Wu Y; Luo L; Li H; Ma L; Yang Z; He Y; Cui L
PLoS One; 2017; 12(5):e0177917. PubMed ID: 28531196
[TBL] [Abstract][Full Text] [Related]
37. Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia.
Matsuoka H; Ishii A; Panjaitan W; Sudiranto R
Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):530-6. PubMed ID: 3576282
[TBL] [Abstract][Full Text] [Related]
38. Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
Pfeffer DA; Ley B; Howes RE; Adu P; Alam MS; Bansil P; Boum Y; Brito M; Charoenkwan P; Clements A; Cui L; Deng Z; Egesie OJ; Espino FE; von Fricken ME; Hamid MMA; He Y; Henriques G; Khan WA; Khim N; Kim S; Lacerda M; Lon C; Mekuria AH; Menard D; Monteiro W; Nosten F; Oo NN; Pal S; Palasuwan D; Parikh S; Pitaloka Pasaribu A; Poespoprodjo JR; Price DJ; Roca-Feltrer A; Roh ME; Saunders DL; Spring MD; Sutanto I; Thriemer K; Weppelmann TA; von Seidlein L; Satyagraha AW; Bancone G; Domingo GJ; Price RN
PLoS Med; 2020 May; 17(5):e1003084. PubMed ID: 32407380
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
Kotepui M; Uthaisar K; PhunPhuech B; Phiwklam N
Infect Dis Poverty; 2016 Apr; 5():36. PubMed ID: 27109515
[TBL] [Abstract][Full Text] [Related]
40. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
